The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

OCUL FINANCIAL STATEMENTS

Ocular Therapeutix Inc — balance sheet, income statement and cash flow trends

OCULOcular Therapeutix Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue52.1 M $Gross Profit45.3 M $ · 87%Operating Income-313.9 M $ · -603%Pre-tax Income-301.4 M $ · -579%Net Income to Owners-301.4 M $ · -579%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue52.1 M $-8.1%
Gross Profit45.3 M $-10.5%
Operating Income-313.9 M $—
EBITDA-284.6 M $—
Net Income to Owners-301.4 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0250 M500 M750 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets671.3 M
  • Equity520 M $77%
  • Current Liabilities49.2 M $7%
  • Long-term Liabilities102.1 M $15%

Key Figures

YoY change
Total Assets671.3 M $+48.7%
Total Liabilities151.3 M $+4.0%
Total Equity520 M $+70.0%
Cash & ST Investments598.6 M $+53.1%
Total Debt79.4 M $+3.2%
Net Debt-519.3 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-200 M0200 M-238.2 M $Operating-16.9 M $Investing462.6 M $Financing207.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow-238.2 M $—
Capital Expenditures16.9 M $+386.0%
Free Cash Flow-255.1 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on OCUL

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.